Crescent Capital BDC, Inc. (CCAP) Stock Analysis and Metrics

Sector: Financial Services Industry: Asset Management CIK: 0001633336

Market Cap 453.24 Mn

P/E 6.74

P/S 2.71

Div. Yield 0.15

ROIC (Qtr) 0.04

Revenue Growth (1y) (Qtr) -12.08

Add ratio to table...

About

Crescent Capital BDC, Inc., or CCAP, operates as a specialty finance company, focusing on lending to middle-market companies. The company is listed on the NASDAQ stock exchange under the ticker symbol CCAP and is a business development company (BDC) under the Investment Company Act of 1940. CCAP is managed by Crescent Cap Advisors, LLC, an investment adviser registered with the Securities and Exchange Commission (SEC). As a BDC, CCAP's main business activities revolve around providing financing solutions to middle-market companies, which are typically...

Crescent Capital BDC, Inc., or CCAP, operates as a specialty finance company, focusing on lending to middle-market companies. The company is listed on the NASDAQ stock exchange under the ticker symbol CCAP and is a business development company (BDC) under the Investment Company Act of 1940. CCAP is managed by Crescent Cap Advisors, LLC, an investment adviser registered with the Securities and Exchange Commission (SEC).

As a BDC, CCAP's main business activities revolve around providing financing solutions to middle-market companies, which are typically underserved by traditional banking institutions. These companies usually have annual earnings before interest, taxes, depreciation, and amortization (EBITDA) between $10 million and $250 million. CCAP operates in the United States, focusing on debt and equity investments in private middle-market companies.

The company generates revenue through various means, including interest income from debt investments, dividend income from direct equity investments, capital gains on the sales of debt and equity securities, and loan origination and other fees. CCAP's investment strategy is based on fundamental credit research and risk analysis, targeting investments in companies with strong franchises, sustainable competitive advantages, and predictable cash flows.

Within the industry, CCAP competes with a variety of players, including public and private funds, other business development companies, commercial and investment banks, commercial financing companies, and private equity and hedge funds. Many of these competitors are substantially larger and have greater financial, technical, and marketing resources than CCAP. However, CCAP's competitive advantages lie in its investment strategy and approach, which emphasize fundamental credit research and risk analysis.

CCAP's customers include private U.S. middle-market companies with annual EBITDA between $10 million and $250 million. These companies often have limited access to traditional capital markets and are in need of flexible financing solutions. CCAP's investments in these companies are generally rated below investment grade, and the company may invest in high-yield debt, or junk bonds, which have greater credit and liquidity risk than more highly rated debt obligations.

Some of the brand names and/or trade names of CCAP's products and services include first lien, unitranche first lien, and second-lien debt, as well as unsecured debt and related equity securities. These investments are tailored to the specific needs of middle-market companies, providing them with the necessary capital to grow and succeed in their respective industries.

Investment thesis

Bull case

Crescent Capital BDC’s net investment income per share remained flat at $0.46 despite a modest NAV decline, underscoring the resilience of its core private credit platform. The steady 9.5% annualized NII yield, coupled with a 110% dividend coverage ratio, indicates that earnings can comfortably sustain the $0.42 regular dividend and potentially allow for incremental dividend increases if spread dynamics improve. Management’s explicit focus on floating‑rate borrowings that mirror the portfolio’s floating‑rate structure provides a natural hedge against a further slide in base rates, preserving the net interest margin even in a low‑rate environment. The firm’s debt refinancing program, which replaced most of the 2026 debt with longer‑dated issues and lowered the weighted average borrowing cost to 5.99%, has extended the maturity profile and reduced refinancing risk, positioning the company to deploy capital into higher‑yield opportunities as market conditions permit. The available undrawn capacity of $240 million, in addition to $28 million in liquid cash, gives Crescent the liquidity cushion to seize attractive add‑on deals or opportunistic originations without jeopardizing its leverage target. Furthermore, the private credit platform’s pipeline—over $6 billion committed in the trailing twelve months—provides a substantial source of future earnings, especially if the anticipated uptick in M&A activity driven by lower borrowing costs materializes in 2026. The firm’s disciplined underwriting, with 99% of debt backed by private‑equity sponsors and a 40% loan‑to‑value ratio at underwriting, creates a strong equity cushion that mitigates default risk and preserves portfolio value. Finally, the spread expansion seen in new investments (a weighted average spread of 530 bps) demonstrates that Crescent can maintain attractive yields even as market competition intensifies, giving it a clear path to enhance returns in the coming quarters.

Crescent Capital BDC’s net investment income per share remained flat at $0.46 despite a modest NAV decline, underscoring the resilience of its core private credit platform. The steady 9.5% annualized NII yield, coupled with a 110% dividend coverage ratio, indicates that earnings can comfortably sustain the $0.42 regular dividend and potentially allow for incremental dividend increases if spread dynamics improve. Management’s explicit focus on floating‑rate borrowings that mirror the portfolio’s floating‑rate structure provides a natural hedge against a further slide in base rates, preserving the net interest margin even in a low‑rate environment. The firm’s debt refinancing program, which replaced most of the 2026 debt with longer‑dated issues and lowered the weighted average borrowing cost to 5.99%, has extended the maturity profile and reduced refinancing risk, positioning the company to deploy capital into higher‑yield opportunities as market conditions permit. The available undrawn capacity of $240 million, in addition to $28 million in liquid cash, gives Crescent the liquidity cushion to seize attractive add‑on deals or opportunistic originations without jeopardizing its leverage target. Furthermore, the private credit platform’s pipeline—over $6 billion committed in the trailing twelve months—provides a substantial source of future earnings, especially if the anticipated uptick in M&A activity driven by lower borrowing costs materializes in 2026. The firm’s disciplined underwriting, with 99% of debt backed by private‑equity sponsors and a 40% loan‑to‑value ratio at underwriting, creates a strong equity cushion that mitigates default risk and preserves portfolio value. Finally, the spread expansion seen in new investments (a weighted average spread of 530 bps) demonstrates that Crescent can maintain attractive yields even as market competition intensifies, giving it a clear path to enhance returns in the coming quarters.

Bear case

Tariff‑related headwinds have already eroded $0.15 per share of NAV through unrealized losses on two portfolio companies, a figure that management acknowledges will not improve in the near term. Although the firm claims that the overall exposure remains muted, the fact that specific borrowers will need to rely on price increases, supply‑chain adjustments, or customer leverage to weather these tariffs signals a long‑term deterioration in operating outlooks that could translate into higher default risk. The expansion of the watch‑list to 13% of the portfolio, with a gap of 11% relative to non‑accruals, indicates that a larger portion of the book is under increased scrutiny, raising the possibility that more non‑accruals may materialize as the underlying businesses’ earnings normalize. Management’s reassurance that the base rate environment will gradually reduce yields could be overly optimistic, as the portfolio’s heavy exposure to floating‑rate loans may still be vulnerable to rate volatility, particularly if the Federal Reserve signals a tightening cycle or if supply‑chain disruptions drive up costs. The company’s fee income, which has already slipped to about a third of its historical run rate, is a significant portion of its total earnings; a continued decline in fee revenue would squeeze margins further, especially if spread compression continues in the lower and core markets. While Crescent claims to be well‑capitalized, the debt‑to‑equity ratio of 1.20x sits at the upper end of its target range, leaving little room for additional leverage in the event that opportunities arise or if the firm needs to shore up the balance sheet amid tightening spreads. Moreover, the firm’s heavy reliance on sponsor‑backed deals exposes it to the performance and exit strategies of external partners, which can be unpredictable in a volatile macro environment. Finally, the competitive pressure in the core and lower middle market, as evidenced by peers tightening covenants and narrowing spreads, suggests that Crescent’s ability to sustain its current spread levels may erode, potentially reducing future NII and threatening dividend sustainability.

Tariff‑related headwinds have already eroded $0.15 per share of NAV through unrealized losses on two portfolio companies, a figure that management acknowledges will not improve in the near term. Although the firm claims that the overall exposure remains muted, the fact that specific borrowers will need to rely on price increases, supply‑chain adjustments, or customer leverage to weather these tariffs signals a long‑term deterioration in operating outlooks that could translate into higher default risk. The expansion of the watch‑list to 13% of the portfolio, with a gap of 11% relative to non‑accruals, indicates that a larger portion of the book is under increased scrutiny, raising the possibility that more non‑accruals may materialize as the underlying businesses’ earnings normalize. Management’s reassurance that the base rate environment will gradually reduce yields could be overly optimistic, as the portfolio’s heavy exposure to floating‑rate loans may still be vulnerable to rate volatility, particularly if the Federal Reserve signals a tightening cycle or if supply‑chain disruptions drive up costs. The company’s fee income, which has already slipped to about a third of its historical run rate, is a significant portion of its total earnings; a continued decline in fee revenue would squeeze margins further, especially if spread compression continues in the lower and core markets. While Crescent claims to be well‑capitalized, the debt‑to‑equity ratio of 1.20x sits at the upper end of its target range, leaving little room for additional leverage in the event that opportunities arise or if the firm needs to shore up the balance sheet amid tightening spreads. Moreover, the firm’s heavy reliance on sponsor‑backed deals exposes it to the performance and exit strategies of external partners, which can be unpredictable in a volatile macro environment. Finally, the competitive pressure in the core and lower middle market, as evidenced by peers tightening covenants and narrowing spreads, suggests that Crescent’s ability to sustain its current spread levels may erode, potentially reducing future NII and threatening dividend sustainability.

Investment, Issuer Affiliation Breakdown of Revenue (2025)

Peer comparison

Companies in the Asset Management

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	BLK	BlackRock, Inc.	148.46 Bn	26.72	6.13	8.43 Bn
2	AMP	Ameriprise Financial Inc	147.62 Bn	11.84	7.71	0.20 Bn
3	BX	Blackstone Inc.	85.60 Bn	29.47	5.92	12.45 Bn
4	KKR	KKR & Co. Inc.	81.44 Bn	36.25	6.61	-
5	BAM	Brookfield Asset Management Ltd.	70.90 Bn	27.38	16.18	2.48 Bn
6	STT	State Street Corp	64.62 Bn	13.42	4.63	-
7	APO	Apollo Global Management, Inc.	63.83 Bn	19.79	-22.85	-
8	RJF	Raymond James Financial Inc	35.86 Bn	13.78	2.61	3.52 Bn

Research Tools

Crescent Capital BDC, Inc. (NASDAQ: CCAP)

About

Investment thesis

Bull case

Bear case

Investment, Issuer Affiliation Breakdown of Revenue (2025)

Peer comparison

Research Tools

Crescent Capital BDC, Inc. (NASDAQ: CCAP)

About

Investment thesis

Bull case

Bear case

Investment, Issuer Affiliation Breakdown of Revenue (2025)

Peer comparison

Create an account

Sign In

Reset Password